ConductScience.org, home

Paper36713447

CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX.

Whelan JT and 26 others. Front Immunol, 2022. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX. Papers, record 36713447. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36713447

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX.
PubMed
Journal
Front Immunol
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
1.24
iCite
Revised in PubMed
2024-09-11
PubMed

Authors27

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Whelan JTJack T
2Singaravelu RRagunath
3Wang FFuan
4Pelin AAdrian
5Tamming LALevi A
6Pugliese GGiuseppe
7Martin NTNikolas T
8Crupi MJFMathieu J F
9Petryk JJulia
10Austin BBradley
11He XXiaohong
12Marius RRicardo
13Duong JJessie
14Jones CCarter
15Fekete EEFEmily E F
16Alluqmani NNouf
17Chen AAndrew
18Boulton SStephen
19Huh MSMichael S
20Tang MYMatt Y

Source PubMed

See all 27 authorsDownload CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
PoxviridaeMajor topic
NeoplasmsMajor topic
Humans
Animals
Mice
Genetic Vectors
Vaccinia virus
Immunotherapy

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CIHRCanadaPubMed

Source PubMed

Download CSV of grants

References74

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131011628The Enhanced Tumor Specificity of TG6002, an Armed Oncolytic Vaccinia Virus Deleted in Two Genes Involved in Nucleotide Metabolism.Mol Ther Oncolytics2019https://conductscience.org/library/papers/31011628PubMed
223769666Structure and signaling mechanism of a zinc-sensory diguanylate cyclase.Structure2013https://conductscience.org/library/papers/23769666PubMed
336015016Poxvirus Recombination.Pathogens2022https://conductscience.org/library/papers/36015016PubMed
432668227Structures and Mechanisms in the cGAS-STING Innate Immunity Pathway.Immunity2020https://conductscience.org/library/papers/32668227PubMed
527043414S6K-STING interaction regulates cytosolic DNA-mediated activation of the transcription factor IRF3.Nat Immunol2016https://conductscience.org/library/papers/27043414PubMed
629676720Mutagenic repair of double-stranded DNA breaks in vaccinia virus genomes requires cellular DNA ligase IV activity in the cytosol.J Gen Virol2018https://conductscience.org/library/papers/29676720PubMed
72587253Vaccinia virus encodes a polypeptide with DNA ligase activity.Nucleic Acids Res1989https://conductscience.org/library/papers/2587253PubMed
811119568Vaccinia virus vectors with an inactivated gamma interferon receptor homolog gene (B8R) are attenuated In vivo without a concomitant reduction in immunogenicity.J Virol2001https://conductscience.org/library/papers/11119568PubMed
925959818Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity.Cell Rep2015https://conductscience.org/library/papers/25959818PubMed
1025741005Efficiently editing the vaccinia virus genome by using the CRISPR-Cas9 system.J Virol2015https://conductscience.org/library/papers/25741005PubMed
1130587523Ovarian Cancer Cells Commonly Exhibit Defective STING Signaling Which Affects Sensitivity to Viral Oncolysis.Mol Cancer Res2019https://conductscience.org/library/papers/30587523PubMed
1235169141Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancer.Nat Commun2022https://conductscience.org/library/papers/35169141PubMed
1327094534CRISPRs for Optimal Targeting: Delivery of CRISPR Components as DNA, RNA, and Protein into Cultured Cells and Single-Cell Embryos.Hum Gene Ther2016https://conductscience.org/library/papers/27094534PubMed
1426792800In Vivo Synthesis of Cyclic-di-GMP Using a Recombinant Adenovirus Preferentially Improves Adaptive Immune Responses against Extracellular Antigens.J Immunol2016https://conductscience.org/library/papers/26792800PubMed
156951197Molecular genetics of vaccinia virus: demonstration of marker rescue.Proc Natl Acad Sci U S A1982https://conductscience.org/library/papers/6951197PubMed
1630300041Poxvirus-based vector systems and the potential for multi-valent and multi-pathogen vaccines.Expert Rev Vaccines2018https://conductscience.org/library/papers/30300041PubMed
1721886163Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans.Nature2011https://conductscience.org/library/papers/21886163PubMed
1826780180Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9.Nat Biotechnol2016https://conductscience.org/library/papers/26780180PubMed
1933833439The cGAS-STING pathway as a therapeutic target in inflammatory diseases.Nat Rev Immunol2021https://conductscience.org/library/papers/33833439PubMed
2032483165Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity.Nat Commun2020https://conductscience.org/library/papers/32483165PubMed

See all 74 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
42196288Therapeutic Innovations for Monkeypox Inhibition.Int J Mol Sci2026https://conductscience.org/library/papers/42196288PubMed
41957020Developing a multimodal therapy for glioblastoma using oncolytic virus delivering CD19 and EGFRvIII antigens and bi-specific CARs.Nat Commun2026https://conductscience.org/library/papers/41957020PubMed
41675688Identification and evaluation of novel intergenic sites in the vaccinia virus genome for transgene insertion.Mol Ther Oncol2026https://conductscience.org/library/papers/41675688PubMed
40789743Universal off-the-shelf combination immunotherapy using oncolytic viruses to redirect T cell engagers to target solid tumors.J Immunother Cancer2025https://conductscience.org/library/papers/40789743PubMed
40725333CRISPR/Cas9-Mediated Knockout of the Corazonin Gene Indicates Its Regulation on the Cuticle Development of Desert Locusts (Schistocerca gregaria).Insects2025https://conductscience.org/library/papers/40725333PubMed
40143547Oncolytic viruses as cancer therapeutics: From mechanistic insights to clinical translation.Mol Ther2025https://conductscience.org/library/papers/40143547PubMed
39726634Advances in CRISPR-Cas technology and its applications: revolutionising precision medicine.Front Genome Ed2024https://conductscience.org/library/papers/39726634PubMed
39621264Cas9-Mediated Poxvirus Recombinant Recovery (CASPRR) for Fast Recovery of Recombinant Vaccinia Viruses.Methods Mol Biol2025https://conductscience.org/library/papers/39621264PubMed
39609558Antibiotic-mediated selection of randomly mutagenized and cytokine-expressing oncolytic viruses.Nat Biomed Eng2025https://conductscience.org/library/papers/39609558PubMed
39179564Complementary dual-virus strategy drives synthetic target and cognate T-cell engager expression for endogenous-antigen agnostic immunotherapy.Nat Commun2024https://conductscience.org/library/papers/39179564PubMed
38139802At the Crossroads of the cGAS-cGAMP-STING Pathway and the DNA Damage Response: Implications for Cancer Progression and Treatment.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/38139802PubMed
38022679Charting a killer course to the solid tumor: strategies to recruit and activate NK cells in the tumor microenvironment.Front Immunol2023https://conductscience.org/library/papers/38022679PubMed

Download CSV of cited by

Genes22

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CGAS115004PubTator's text mininghttps://conductscience.org/library/genes/115004NCBI Gene
CSF11435PubTator's text mininghttps://conductscience.org/library/genes/1435NCBI Gene
GEN1348654PubTator's text mininghttps://conductscience.org/library/genes/348654NCBI Gene
IFIT13434PubTator's text mininghttps://conductscience.org/library/genes/3434NCBI Gene
IFNA13439PubTator's text mininghttps://conductscience.org/library/genes/3439NCBI Gene
IFNA83445PubTator's text mininghttps://conductscience.org/library/genes/3445NCBI Gene
IFNB13456PubTator's text mininghttps://conductscience.org/library/genes/3456NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IRF33661PubTator's text mininghttps://conductscience.org/library/genes/3661NCBI Gene
LIG43981PubTator's text mininghttps://conductscience.org/library/genes/3981NCBI Gene
MAP3K76885PubTator's text mininghttps://conductscience.org/library/genes/6885NCBI Gene
NFKB14790PubTator's text mininghttps://conductscience.org/library/genes/4790NCBI Gene
NT5C30833PubTator's text mininghttps://conductscience.org/library/genes/30833NCBI Gene
POTEF728378PubTator's text mininghttps://conductscience.org/library/genes/728378NCBI Gene
RSAD155316PubTator's text mininghttps://conductscience.org/library/genes/55316NCBI Gene
RSAD291543PubTator's text mininghttps://conductscience.org/library/genes/91543NCBI Gene
SPATA29825PubTator's text mininghttps://conductscience.org/library/genes/9825NCBI Gene
STING1340061PubTator's text mininghttps://conductscience.org/library/genes/340061NCBI Gene

See all 22 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36713447

GET https://conductscience.org/api/papers/v1/36713447/authors?page=2